1 Floor, No.280, Xinhu 2nd Road, Neihu District
Tel: 886 2 2795 3660
Fax: 886 2 2795 5016
6 articles with ACT Genomics
ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital.
ACT Genomics completed investment on route to become the leading DNA sequencing-based cancer solution provider in Asia
ACT Genomics Holdings Company Limited is pleased to announce the completion of the latest round of equity financing.
ACT Genomics is honored to collaborate with AstraZeneca Singapore for both somatic and germline genetic testing of BRCA in patients with ovarian cancer, using the advanced next generation sequencing.
ACT Genomics Receives CAP Accreditation, Offering Full-Scale And Comprehensive Clinical Services To Transform Cancer Care